Lantern Pharma Inc. (LTRN)
3.52
0.03 (0.86%)
At close: Jan 15, 2025, 2:26 PM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost of Revenue | 174.84K | 154.68K | 97.42K | 3.39K | 1.63K | -2.54K |
| Gross Profit | -174.84K | -154.68K | -97.42K | -3.39K | -1.63K | 2.54K |
| Operating Income | -17.88M | -14.43M | -12.59M | -5.91M | -2.43M | -1.73M |
| Interest Income | 765.39K | 204.35K | 67.93K | n/a | n/a | n/a |
| Pretax Income | -15.96M | -14.26M | -12.36M | -5.91M | -2.43M | -1.73M |
| Net Income | -15.96M | -14.09M | -12.30M | -5.91M | -2.43M | -1.73M |
| Selling & General & Admin | 5.98M | 5.83M | 5.02M | 3.66M | 1.48M | 1.15M |
| Research & Development | 11.89M | 8.60M | 7.57M | 2.24M | 953.18K | 572.10K |
| Other Expenses | n/a | -31.55K | 160.55K | n/a | n/a | n/a |
| Operating Expenses | 17.88M | 14.43M | 12.59M | 5.91M | 2.43M | 1.73M |
| Interest Expense | n/a | 204.35K | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 17.88M | 14.43M | 12.59M | 5.91M | 2.43M | 1.73M |
| Income Tax | n/a | -172.81K | -67.93K | -202.91K | -5 | 2.54K |
| Shares Outstanding (Basic) | 10.84M | 10.85M | 10.90M | 6.22M | 6.27M | 6.22M |
| Shares Outstanding (Diluted) | 10.84M | 10.85M | 10.90M | 6.22M | 6.27M | 6.22M |
| EPS (Basic) | -1.47 | -1.3 | -1.13 | -0.95 | -0.39 | -0.28 |
| EPS (Diluted) | -1.47 | -1.3 | -1.13 | -0.95 | -0.39 | -0.28 |
| EBITDA | -15.79M | -14.42M | -12.27M | -5.90M | -2.43M | -1.73M |
| Depreciation & Amortization | 174.84K | 154.68K | 97.42K | 3.39K | 1.63K | -2.54K |